Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04077398Phase 4Withdrawn
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Visual Analogue Scale for Pain at 72 hours. Planned start Jan 2020; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04077398.